Literature DB >> 17101132

Nek7 kinase is enriched at the centrosome, and is required for proper spindle assembly and mitotic progression.

Nissan Yissachar1, Hagit Salem, Tamar Tennenbaum, Benny Motro.   

Abstract

Members of the NIMA-related kinases (NRK) family are recently emerging as central regulators of various aspects of the cell cycle. However, the cellular roles of the mammalian NRK, Nek7, remain obscure. We show here that the endogenous Nek7 protein is enriched at the centrosome in a microtubule-independent manner. Overexpression of wt or kinase-defective Nek7 resulted in cells of rounder appearance, and higher proportions of multinuclear and apoptotic cells. Down-regulation of Nek7 using a small interfering RNA approach resulted in a significant increase in mitotic cells presenting multipolar spindle phenotype. These results suggest a role for Nek7 in regulating proper spindle assembly and mitotic progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101132     DOI: 10.1016/j.febslet.2006.10.069

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  47 in total

1.  The Nek6 and Nek7 protein kinases are required for robust mitotic spindle formation and cytokinesis.

Authors:  Laura O'Regan; Andrew M Fry
Journal:  Mol Cell Biol       Date:  2009-05-04       Impact factor: 4.272

2.  Nek7 Protects Telomeres from Oxidative DNA Damage by Phosphorylation and Stabilization of TRF1.

Authors:  Rong Tan; Satoshi Nakajima; Qun Wang; Hongxiang Sun; Jing Xue; Jian Wu; Sabine Hellwig; Xuemei Zeng; Nathan A Yates; Thomas E Smithgall; Ming Lei; Yu Jiang; Arthur S Levine; Bing Su; Li Lan
Journal:  Mol Cell       Date:  2017-02-16       Impact factor: 17.970

3.  Human Nek7-interactor RGS2 is required for mitotic spindle organization.

Authors:  Edmarcia Elisa de Souza; Heidi Hehnly; Arina Marina Perez; Gabriela Vaz Meirelles; Juliana Helena Costa Smetana; Stephen Doxsey; Jörg Kobarg
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases.

Authors:  C I Wells; N R Kapadia; R M Couñago; D H Drewry
Journal:  Medchemcomm       Date:  2017-12-08       Impact factor: 3.597

Review 5.  "Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases.

Authors:  Gabriela Vaz Meirelles; Arina Marina Perez; Edmárcia Elisa de Souza; Fernanda Luisa Basei; Priscila Ferreira Papa; Talita Diniz Melo Hanchuk; Vanessa Bomfim Cardoso; Jörg Kobarg
Journal:  World J Biol Chem       Date:  2014-05-26

6.  Nek9 is a Plk1-activated kinase that controls early centrosome separation through Nek6/7 and Eg5.

Authors:  M Teresa Bertran; Sara Sdelci; Laura Regué; Joseph Avruch; Carme Caelles; Joan Roig
Journal:  EMBO J       Date:  2011-06-03       Impact factor: 11.598

7.  Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats.

Authors:  Hung-Ming Lam; Shuk-Mei Ho; Jing Chen; Mario Medvedovic; Neville Ngai Chung Tam
Journal:  Endocrinology       Date:  2015-10-23       Impact factor: 4.736

Review 8.  Mitotic kinase cascades orchestrating timely disjunction and movement of centrosomes maintain chromosomal stability and prevent cancer.

Authors:  Janine H van Ree; Hyun-Ja Nam; Jan M van Deursen
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

9.  Structural analysis of the regulation of the DYNLL/LC8 binding to Nek9 by phosphorylation.

Authors:  Pablo Gallego; Adrian Velazquez-Campoy; Laura Regué; Joan Roig; David Reverter
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

10.  An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9.

Authors:  Mark W Richards; Laura O'Regan; Corine Mas-Droux; Joelle M Y Blot; Jack Cheung; Swen Hoelder; Andrew M Fry; Richard Bayliss
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.